Lido Advisors’s TherapeuticsMD TXMD Stock Holding History

Lido Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,391	Closed	-$133K	–	1037
2022 Q2	$133K	Buy	13,391 +13,047	+3,793%	+$125K	﹤0.01%	895
2022 Q1	$6K	Hold	344	–	–	﹤0.01%	981
2021 Q4	$6K	Hold	344	–	–	﹤0.01%	987
2021 Q3	$12K	Hold	344	–	–	﹤0.01%	956
2021 Q2	$20K	Hold	344	–	–	﹤0.01%	901
2021 Q1	$23K	Hold	344	–	–	﹤0.01%	832
2020 Q4	$20K	Hold	344	–	–	﹤0.01%	803
2020 Q3	$27K	Hold	344	–	–	﹤0.01%	629
2020 Q2	$21K	Hold	344	–	–	﹤0.01%	595
2020 Q1	$18K	Hold	344	–	–	﹤0.01%	578
2019 Q4	$42K	Hold	344	–	–	﹤0.01%	649
2019 Q3	$62K	Hold	344	–	–	﹤0.01%	567
2019 Q2	$44K	Buy	344 +78	+29%	+$14K	﹤0.01%	532
2019 Q1	$64K	Hold	266	–	–	﹤0.01%	514
2018 Q4	$50K	Hold	266	–	–	﹤0.01%	430
2018 Q3	$87K	Hold	266	–	–	0.01%	444
2018 Q2	$83K	Hold	266	–	–	0.01%	415
2018 Q1	$64K	Hold	266	–	–	0.01%	392
2017 Q4	$80K	Hold	266	–	–	0.01%	300
2017 Q3	$62K	Buy	+266	New	+$76.9K	0.01%	280
2017 Q2	–	Sell	-266	Closed	-$56K	–	281
2017 Q1	$56K	Hold	266	–	–	0.02%	236
2016 Q4	$77K	Hold	266	–	–	0.02%	215
2016 Q3	$91K	Hold	266	–	–	0.03%	147
2016 Q2	$113K	Hold	266	–	–	0.03%	150
2016 Q1	$85K	Buy	+266	New	+$90.7K	0.03%	142

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Lido Advisors's TXMD Position: Q3 2022 in Review

Lido Advisors sold out of TherapeuticsMD (TXMD) in Q3 2022, closing a stake of 13,391 shares — an estimated $133K sold.

Lido Advisors first reported a position in TXMD in Q1 2016 and held it in 25 quarters. The position peaked at $133K in Q2 2022. 43 funds tracked by Wall St. Rank hold TXMD as of Q3 2022.

Lido Advisors reported no remaining TherapeuticsMD position as of Q3 2022 after selling out during the quarter.
Lido Advisors sold 13,391 TherapeuticsMD shares in Q3 2022, an estimated $133K.
Lido Advisors first reported a position in TherapeuticsMD in Q1 2016 and held it in 25 quarters.
Lido Advisors's TherapeuticsMD position peaked at $133K in Q2 2022.
43 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2022.

Based on Lido Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.